Evidence map›Paper›PMID 36054288›Full record

ArticleHuman mutation2022

A calibrated cell-based functional assay to aid classification of MLH1 DNA mismatch repair gene variants.

Abhijit Rath, Alexander A Radecki, Kaussar Rahman, Rachel B Gilmore, Jonathan R Hudson, Matthew Cenci, Sean V Tavtigian, James P Grady, Christopher D Heinen

Open access · greenAbstract read
In one paragraph

Article in Human mutation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. An accurate cellular assay to determine pathogenicity of coding and noncoding variants in Lynch syndrome genes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Abhijit RathCenter for Molecular Oncology, UConn Health, Farmington, Connecticut, USA.
Alexander A RadeckiCenter for Molecular Oncology, UConn Health, Farmington, Connecticut, USA.
Kaussar RahmanCenter for Molecular Oncology, UConn Health, Farmington, Connecticut, USA.
Rachel B GilmoreDepartment of Genetics and Genome Sciences, UConn Health, Farmington, Connecticut, USA.
Jonathan R HudsonDepartment of Genetics and Genome Sciences, UConn Health, Farmington, Connecticut, USA.
Matthew CenciCenter for Molecular Oncology, UConn Health, Farmington, Connecticut, USA.
Sean V TavtigianDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0002-7543-8221
James P GradyConnecticut Institute for Clinical and Translational Science, UConn Health, Farmington, Connecticut, USA.
Christopher D HeinenCenter for Molecular Oncology, UConn Health, Farmington, Connecticut, USA.ORCID 0000-0003-4338-6858
University of Connecticut · USUConn Health · USUniversity of Utah · US

Funding

Classifying DNA Mismatch Repair Gene Variants of Unknown SignificanceR01CA164944 · NCI · UNIVERSITY OF UTAH · PI GREENBLATT, MARC S, TAVTIGIAN, SEAN VAHRAM · 2013 to 2016
$2.2M
Hereditary Cancer Variants of Uncertain Significance in Stem CellsR01CA222477 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HEINEN, CHRISTOPHER D. · 2019 to 2024
$1.9M
Saturation genome editing approach to functionally test all possible MSH2 variantsR21CA237920 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COTNEY, JUSTIN LEE, HEINEN, CHRISTOPHER D. · 2020 to 2021
$422k
NCI NIH HHS R01 CA164944NCI NIH HHS R01 CA222477NCI NIH HHS R21 CA237920
6 · The paper itself

Abstract

Functional assays provide important evidence for classifying the disease significance of germline variants in DNA mismatch repair genes. Numerous laboratories, including our own, have developed functional assays to study mismatch repair gene variants. However, previous assays are limited due to the model system employed, the manner of gene expression, or the environment in which function is assessed. Here, we developed a human cell-based approach for testing the function of variants of uncertain significance (VUS) in the MLH1 gene. Using clustered regularly interspaced short palindromic repeats gene editing, we knocked in MLH1 VUS into the endogenous MLH1 loci in human embryonic stem cells. We examined their impact on RNA and protein, including their ability to prevent microsatellite instability and instigate a DNA damage response. A statistical clustering analysis determined the range of functions associated with known pathogenic or benign variants, and linear regression was performed using existing odds in favor of pathogenicity scores for these control variants to calibrate our functional assay results. By converting the functional outputs into a single odds in favor of pathogenicity score, variant classification expert panels can use these results to readily reassess these VUS. Ultimately, this information will guide proper diagnosis and disease management for suspected Lynch syndrome patients.

Indexed as

Colorectal Neoplasms, Hereditary NonpolyposisDNA Mismatch RepairGerm-Line MutationHumansMicrosatellite InstabilityMismatch Repair Endonuclease PMS2MutL Protein Homolog 1Mismatch Repair Endonuclease PMS2MLH1 protein, humanMutL Protein Homolog 1CRISPR gene editingDNA damage responsefunctional assayLynch syndromemicrosatellite instabilitymismatch repairvariant of uncertain significance

Identifiers

PMID36054288
PMCPMC9772141
OpenAlexW4294295460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.